Media statement: Vaping reform legislation

26 June 2024


The Pharmaceutical Society of Australia (PSA) acknowledges the passing of reforms today that aim to shut down the retail model of vape supply in Australia.


The legislation which has now passed the Senate defines the minimum legal requirements for prescribing as a Pharmacist Only Medicine (Schedule 3). In addition, pharmacists will be expected to adhere to PSA’s Guidelines for pharmacists providing smoking cessation support, which will be updated prior to 1 October 2024.


While the amendments to the legislation are not PSA’s preferred approach, we also recognise the need for strong action to address the vaping public health crisis, and this starts with ending retail supply of vapes.


Quotes attributable to PSA National President Associate Professor Fei Sim:

“PSA has consistently called for strong action to address the public health crisis that vaping has become.


“While this is not our preferred model, PSA remains firm in the belief that something needed to be done to prevent another generation of Australians to becoming addicted to nicotine and experiencing the health consequences of vaping.


“Once legislation has passed both houses, our focus will be firmly on supporting pharmacists through these changes.


“PSA will work with government to support the pharmacists who choose to be involved in the prescribing and dispensing of nicotine-containing therapeutic vapes. PSA will develop best-practice guidelines to describe how pharmacists prescribe products for smoking cessation products, including nicotine-containing therapeutic vapes.


“People will not be able to simply buy vapes on request – they must take part in a therapeutic consultation with a pharmacist who will prescribe a therapy based on clinical need.  It will be very different to how Australians are currently buying vapes.


“The coming months will be critical in ensuring pharmacists and the community have a clear understanding of how this model will work as a health-based approach to nicotine dependence management.”​


Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au